Dec 17th, 2021
Gynuity Celebrates Decision by the U.S. Food and Drug Administration to Loosen Regulations on Mifepristone
Nov 30th, 2021
Updates from Gynuity Health Projects
Nov 29th, 2021
Support Gynuity Health Projects this 2021 Giving Tuesday
Nov 24th, 2021
Gynuity Health Projects Releases its 2020 Annual Report
Oct 22nd, 2021
Gynuity President Presents Alongside Leading Global Experts on Abortion at the FIGO World Congress 2021
Oct 14th, 2021
Launch of a New Website on Period Pills
Sep 28th, 2021
Gynuity Marks International Safe Abortion Day
Sep 23rd, 2021
Gynuity’s TelAbortion Study Will Stop Enrolling at the End of this Month
Sep 9th, 2021
Mexico: Supreme Court Declares Criminal Penalties for Abortion Unconstitutional / México: La Suprema Corte Declara Inconstitucionales Sanciones Penales por Aborto
Jun 10th, 2021
Society of Family Planning Research Fund Grant Announcement: No-Test Medication Abortion
May 3rd, 2021
Gynuity Shares Research and Programmatic Updates in Maternal Health
Apr 13th, 2021
Gynuity’s Research is Primary Source Cited in the U.S. Food and Drug Administration’s Decision to Suspend In-Person Mifepristone Dispensing Requirement
Mar 29th, 2021
Society of Family Planning Research Fund Grant Announcement: Medical Abortion Regimen in the Later First Trimester
Expansion of a Direct-to-Patient Telemedicine Abortion Service in the United States and Experience during the COVID-19 Pandemic
Jan 26th, 2021
Feasibility of Multilevel Pregnancy Tests for Telemedicine Abortion Service Follow-up: A Pilot Study
Jan 22nd, 2021
Missed Period Pills in the News
Jan 12th, 2021
The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre‑Post Intervention Study in Rural Pakistan
Dec 4th, 2020
New York Times article: Why Some Women Might Want 'Missed-Period Pills'
Dec 2nd, 2020
¡Todavía Hay Cupos! Regístrese Para el Curso Que Comienza el 3 de Diciembre de 2020
Nov 24th, 2020
Newsletter November 2020
Oct 30th, 2020
Exploring Potential Interest in Missed Period Pills in two US States
Sep 21st, 2020
Gynuity Staff Awarded Two Daniel R. Mishell Jr., MD, Outstanding Article Awards
Aug 31st, 2020
New Resources and Articles from Gynuity
Jul 22nd, 2020
A Repeat Dose of Misoprostol 800mcg Following Mifepristone for Outpatient Medical Abortion at 64-70 and 71-77 Days of Gestation: A Retrospective Chart Review
Jun 22nd, 2020
Gynuity’s Recent Articles on Management of Postpartum Hemorrhage
